Cargando…
Trial Watch: Immunostimulatory cytokines
During the last two decades, a number of approaches for the activation of the immune system against cancer has been developed. These include highly specific interventions, such as monoclonal antibodies, vaccines and cell-based therapies, as well as relatively unselective strategies, such as the syst...
Autores principales: | Vacchelli, Erika, Galluzzi, Lorenzo, Eggermont, Alexander, Galon, Jerome, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382908/ https://www.ncbi.nlm.nih.gov/pubmed/22754768 |
Ejemplares similares
-
Trial Watch: Immunostimulatory cytokines
por: Vacchelli, Erika, et al.
Publicado: (2013) -
Trial watch: Immunostimulatory cytokines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2014) -
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2014) -
Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013) -
Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)